Adelaide Research & Scholarship: Search

Search

Results 1-10 of 10 (Search time: 0.002 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2005	Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection	Le Mire, M.; Miller, D.; Foster, W.; Burrell, C.; Jilbert, A.
	2001	Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses	Triyatni, M.; Ey, P.; Tran, T.; Le Mire, M.; Qiao, M.; Burrell, C.; Jilbert, A.
	2013	Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro	Noordeen, F.; Vaillant, A.; Jilbert, A.
	2013	Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo	Noordeen, F.; Vaillant, A.; Jilbert, A.
	2010	The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines	Feng, F.; Teoh, C.; Qiao, Q.; Boyle, D.; Jilbert, A.
	2006	DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner	Miller, D.; Kotlarski, I.; Jilbert, A.
	2005	Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection	Foster, W.; Miller, D.; Scougall, C.; Kotlarski, I.; Colonno, R.; Jilbert, A.
	2009	Pre-P Is a Secreted Glycoprotein Encoded as an N-Terminal Extension of the Duck Hepatitis B Virus Polymerase Gene	Cao, F.; Scougall, C.; Jilbert, A.; Travis, J.
	2003	Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection	Foster, W.; Miller, D.; Marion, P.; Colonno, R.; Kotlarski, I.; Jilbert, A.
	2000	Immune responses to duck hepatitis B virus infection	Jilbert, A.; Kotlarski, I.